Insights from ESMO Breast 2024 Annual Meeting


 

ESMO Breast 2024 Insights: "FeDeriCa Trial Final Analysis - Fixed-Dose Combination of Pertuzumab & Trastuzumab for Subcutaneous Injection + Chemo in HER2+ eBC"

54 views
June 21, 2024
0 Comments
Login to view comments. Click here to Login
Videos